The concept of precision medicine is based on the identification of hallmarks of cancer to exploit them as drug targets. The basic idea was that in this way the therapeutic modalities will be more effective and the side effects will be less. Since the majority of these novel modalities are not specific for a cancer-related biological process or a cancer-specific (mutant) target protein, it is not a surprise that we had to learn new type of side effects, because these therapeutics also affect physiological or pathological processes. Even more, in cases of some of these novel therapies we were able to discover new molecular mechanisms of physiological and pathological processes. Identification of the on-target side effects of targeted drugs can help to prevent the development of them or better manage the patients when emerge during cancer therapy.
Adverse effects of ferroptotic therapy: mechanisms and management: Trends in Cancer
Targeting ferroptosis opens new avenues for the development of novel therapeutics
Common side effects associated with targeted therapy and immunotherapy
Cancer Stem Cell (CSC) Inhibitors in Oncology—A Promise for a Better Therapeutic Outcome: State of the Art and Future Perspectives
Targeted therapy for hormone receptor-positive breast cancer
Targeted Therapies for Breast Cancer
A schematic illustration showing targeted therapy against cancer stem
Targeted Cancer Therapies
Metabolic targets for cancer therapy
POR On-Target Side Effects of Targeted Therapeutics of Cancer
Targeted therapy and immunotherapy in the cancer-immunity cycle. The
Targeted Therapy in Cancer
Targeted therapy - Wikipedia
Cancers, Free Full-Text
Targeted Therapy in Cancer